Home › NDC Lookup › J-codes › J0652
J0652

J0652 – Inj, levothyroxine, hikma · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 1 NDC crosswalked per 10 MCG $6.315/unit ASP+6%

📋 J0652 summary

J0652 is a HCPCS Level II J-code used to bill levothyroxine, hikma, billed per 10 MCG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J0652: Levothyroxine Sodium

Code J0652 Billing unit 10 MCG Payment limit $6.315/unit NDC-Crosswalk 1 Quarter Q4 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ0652
DescriptorInj, levothyroxine, hikma
Billing unit10 MCG
Payment limit / unit$6.315
Est. ASP / unit$5.958 est.
Mapped NDCs1
Data periodQ4 2026
Last updated2026-11-20

💊 About Levothyroxine DRUG GUIDE

Oral levothyroxine (tablets, capsules and oral solutions) is used as replacement therapy for hypothyroidism.

This means the thyroid gland, pituitary gland or hypothalamus is not driving enough thyroid hormone, whether the cause was present from birth or developed later.Oral forms are also used to suppress thyroid-stimulating hormone (TSH) as an add-on to surgery and radioiodine therapy for TSH-dependent, well-differentiated thyroid cancer.

Levothyroxine Sodium injection (intravenous) is used only for myxedema coma, a life-threatening emergency of severe hypothyroidism.

Tirosint capsules and Levoxyl are labeled for specific age groups, so check with your prescriber about use in children.

Read the full Levothyroxine drug guide →
Clinical overview from our editorial drug guide for Levothyroxine. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q4 2026

📅 Payment limits effective Q4 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$6.315
Est. ASP / unit
$5.958 est.
Est. after 2% sequester
$6.189
HCPCS dosage
10 MCG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q4 2026.

📉 ASP payment-limit history CMS · 2 QUARTERS

How the Medicare Part B payment limit per 10 MCG for J0652 has moved by quarter (CMS ASP Pricing File). The limit is ASP + 6% and is revised every quarter.
Current · Q4 2026$6.315
Prior · Q3 2026$6.315
Quarter-over-quarter$0.000 (0%)
2-quarter range$6.315 – $6.315
Source: CMS Medicare Part B ASP Pricing File (quarterly). The payment limit equals ASP + 6% (statutory); after the 2% sequester the effective payment is ≈ ASP + 4.3%. Only quarters present in our dataset are shown.

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J0652 = 10 mcg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J0652 WITH EST. MEDICARE PAY

1 NDC map to J0652. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($6.315/unit) × that package's bill units.
NDC (11-digit)DrugLabelerPackageStrength Bill units Est. pay / pkg NADAC / unit StatusSource
24201-0002-01 Levothyroxine Sodium 100 ug/mL INJECTION, SOLUTION Hikma 1 VIAL, SINGLE-DOSE in 1 CARTON (24201-002... 100 ug/mL 10 $63.15 — ● Active CMS + PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

🗺️ Where J0652 is utilized

⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.

📊 What bills under J0652

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient
LEVOTHYROXINE SODIUM 1
NDC products by labeler
Hikma Pharmaceuticals USA Inc. 1

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Not available in current dataset
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q4 2026 · as of 2026-11-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
1 NDC mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J0652 billing FAQ

What is HCPCS code J0652?
J0652 is a HCPCS Level II J-code used to bill Inj, levothyroxine, hikma under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J0652?
One unit of J0652 represents 10 MCG. Report the number of units equal to the dose administered divided by 10 MCG.
How many units of J0652 should I bill?
Divide the dose administered by the code's unit size (10 MCG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J0652?
The Medicare Part B payment limit is $6.315 per unit (Q4 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $6.189 per unit. Payment limits are revised quarterly.
Which NDCs bill under J0652?
1 NDC currently map to J0652 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0652 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.